| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/2004 | US6750058 For treatment and prevention of human and animal diseases; in particular capable of dispensing to suitable target cells nucleic sequences, proteins, peptides and chemical substances via transfection |
| 06/15/2004 | US6750044 For producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from native vegf protein |
| 06/15/2004 | US6750043 Expression vector for use in the expression of heterologous protein in cells |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6750026 To diagnose diseases relating to under- or over-expression of hfgan72 receptor ligands; for treatment of obesity, diabetes, anorexia nervosa, bulimia, cachexia, chronic renal failure, congestive heart failure |
| 06/15/2004 | US6750025 Method of detecting and isolating prion protein and variants thereof |
| 06/15/2004 | US6750019 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 06/15/2004 | US6750012 For identifying compounds that do not induce motor side effects |
| 06/15/2004 | US6750008 Use of peptides for inhibition of human and non-human retroviral, especially hiv, transmission to uninfected cells |
| 06/15/2004 | US6749866 Modulated release from biocompatible polymers |
| 06/15/2004 | US6749855 Treating peripheral resistance in a mammal; modulating the immune response in a mammal |
| 06/15/2004 | US6749854 Use of OX-2 to inhibit fetal loss |
| 06/15/2004 | US6749853 Combined methods and compositions for coagulation and tumor treatment |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749850 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 06/15/2004 | US6749847 Chemokine for use in of tumors |
| 06/15/2004 | US6749846 Assaying the sensitivity of cells of the ewing's sarcoma to interferon-beta, by cultivation and determining caspase-7 expression of the cells |
| 06/15/2004 | US6749845 Modulated release particles for lung delivery |
| 06/15/2004 | US6749587 Modular infusion device and method |
| 06/15/2004 | CA2329800C Protein formulations |
| 06/15/2004 | CA2285921C Composition and method for treatment of cmv infections |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/15/2004 | CA2109256C Technetium or rhenium-binding bi-hapten derivatives, a process for their preparation, diagnostic and therapeutic application, and kits and immunological reagents containing same |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004048971A1 Methods of protecting against radiation damage using alpha thymosin |
| 06/10/2004 | WO2004048610A1 Methods of diagnosing and treating diabetes and obesity |
| 06/10/2004 | WO2004048601A2 Modulation of b7h expression |
| 06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
| 06/10/2004 | WO2004048581A1 Method for expressing inducible rnai in cells, nucleic acid molecules therefor and cells transformed by said molecules |
| 06/10/2004 | WO2004048577A1 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048570A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004048565A1 Apoptosis-associated protein and use thereof |
| 06/10/2004 | WO2004048558A2 Heparanase mediated cell adhesion and uses thereof |
| 06/10/2004 | WO2004048534A2 Modulation of cytokine-inducible kinase expression |
| 06/10/2004 | WO2004048533A2 Modulation of forkhead box c2 expression |
| 06/10/2004 | WO2004048526A2 MODULATION OF HIF1α AND HIF2α EXPRESSION |
| 06/10/2004 | WO2004048519A2 Treatment of mammalian reaction to ige interactions |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048421A2 Branched cationic copolymers and methods for antimicrobial use |
| 06/10/2004 | WO2004048411A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | WO2004048409A2 Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids |
| 06/10/2004 | WO2004048407A1 Antimicrobial peptide isolated from halocynthia aurantium |
| 06/10/2004 | WO2004048406A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | WO2004048405A1 Elastin substitute |
| 06/10/2004 | WO2004048402A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | WO2004048401A1 Peptides and medicinal compositions containing the same |
| 06/10/2004 | WO2004048400A1 Peptide gap junction modulators |
| 06/10/2004 | WO2004048325A2 Modulation of jagged 1 expression |
| 06/10/2004 | WO2004048324A2 Chemokine parc suppresses specific cytokine production |
| 06/10/2004 | WO2004047881A1 Calcium phosphate carrying protein, process for producing the same and sustained release protein preparation, artificial bone and tissue enginerring scaffold using the same |
| 06/10/2004 | WO2004047866A2 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 06/10/2004 | WO2004047859A2 Prekallikrein depleted plasma derived albumin fraction |
| 06/10/2004 | WO2004047858A1 Novel use of erythropoietin in heart diseases |
| 06/10/2004 | WO2004047857A1 Use of fgf-18 in the diagnosis and treatment of memory disorders |
| 06/10/2004 | WO2004047856A1 Cancer metastasis inhibitor |
| 06/10/2004 | WO2004047855A2 Proteins involved in the regulation of energy homeostasis |
| 06/10/2004 | WO2004047853A2 Methods for the treatment of chronic pain and compositions therefor |
| 06/10/2004 | WO2004047852A1 PHARMACEUTICAL COMPOSITION FOR CONTROLING THE STABILITY OF HIF-1α |
| 06/10/2004 | WO2004047851A1 Method of inhibiting cell death, cell death inhibitor and remedy for disease caused by cell death containing the cell death inhibitor |
| 06/10/2004 | WO2004047812A1 Hollow nanoparticles of protein and drug using the same |
| 06/10/2004 | WO2004047807A1 Artificial blood on the basis of encapsulted haemoglobin |
| 06/10/2004 | WO2004047772A2 Catalytic antioxidants and methods of use |
| 06/10/2004 | WO2004047771A2 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 06/10/2004 | WO2004047766A2 Treatment for sma disease |
| 06/10/2004 | WO2004047765A2 Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047759A2 Composition for treating chlamydia infections and method for identifying same |
| 06/10/2004 | WO2004047758A2 Methods of therapy and diagnosis using targeting of cells that express p2y10 |
| 06/10/2004 | WO2004047750A2 Modulation of notch2 expression |
| 06/10/2004 | WO2004047747A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | WO2004047740A2 Composition and method for treating lupus nephritis |
| 06/10/2004 | WO2004047735A2 Broad spectrum anti-viral therapeutics and prophylaxis |
| 06/10/2004 | WO2004047733A2 Anti-tumor metallocomplexes of crude extract from canavalia ensiformis |
| 06/10/2004 | WO2004047731A2 Modulation of notch3 expression |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004047727A2 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | WO2004047720A2 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 06/10/2004 | WO2004047622A2 Substantially non-immunogenic injectable collagen |
| 06/10/2004 | WO2004047566A1 Nutritional compositions |
| 06/10/2004 | WO2004047530A1 Transgenic model expressing a prp gene homozygous for m129 |
| 06/10/2004 | WO2004037202A9 Gb virus c and methods of treating viral infections |
| 06/10/2004 | WO2004034995A9 Methods and reagents for inducing immunity |
| 06/10/2004 | WO2004033717B1 Autism gene |
| 06/10/2004 | WO2004033672A3 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 06/10/2004 | WO2004033484A3 Use of stable glutamine derivatives to improve drug absorption |
| 06/10/2004 | WO2004030524A3 Treatment of autism and similar disorders |
| 06/10/2004 | WO2004024887A9 Centrosome proteins and uses thereof |
| 06/10/2004 | WO2004022000A3 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 06/10/2004 | WO2004020468A3 Interferon beta-like molecules for treatment of cancer |
| 06/10/2004 | WO2004017810A3 Tumor specific oligosaccharide epitopes and use thereof |
| 06/10/2004 | WO2004016763A3 Treatment of holocrine gland dysfunction with clostridia neurotoxins |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004011647A8 Modified small interfering rna molecules and methods of use |
| 06/10/2004 | WO2004011484A9 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 06/10/2004 | WO2004010954A3 Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 06/10/2004 | WO2004006950A3 Use of cd152 for treating autoimmune diseases and inflammations |
| 06/10/2004 | WO2004006856A3 Iron sequestration or elimination to reduce neurodegeneration or parkinsons disease progression |
| 06/10/2004 | WO2004005331A3 Peptides derived from pep133 (g1p3, 6-16) |